Characteristic | Value |
---|---|
Demographic parameters | |
Sex, F/M | 23/2 |
Age, mean (SD), years | 59 (12.6) |
Disease duration, mean (SD), years | 6.3 (8.8) |
Laboratory parameters | |
ESR, mean (mm/h) (SD) | 17.6 (9.3) |
CRP, mean (mg/dL) (SD) | 0.68 (0.65) |
RF positivity, n (%) | 19 (76) |
ACPA positivity, n (%) | 18 (72) |
Disease activity | |
TJ n, mean (SD) | 5.8 (5.4) |
SJ n, mean (SD) | 2.6 (2.4) |
CDAI, mean (SD) | 19.3 (10.8) |
DAS28, mean (SD) | 4.2 (1.6) |
Therapy | |
Etanercept, n (%) | 20 (80) |
Adalimumab, n (%) | 5 (20) |
Concurrent MTX, n (%) | 13 (52) |